[1] |
赵辨. 中国临床皮肤病学[M]. 南京: 江苏科学技术出版社, 2010:1037.
|
[2] |
中华医学会皮肤性病学分会药物不良反应研究中心. Stevens⁃Johnson综合征/中毒性表皮坏死松解症诊疗专家共识[J]. 中华皮肤科杂志, 2021,54(5):376⁃381. doi: 10.35541/cjd.2020 1177.
|
[3] |
Patel RA, Gallagher JC. Drug fever[J]. Pharmacotherapy, 2010,30(1):57⁃69. doi: 10.1592/phco.30.1.57.
|
[4] |
万学红, 卢雪峰. 诊断学[M] . 北京: 人民卫生出版社, 2018:8⁃12.
|
[5] |
中华医学会肝病学分会药物性肝病学组. 药物性肝损伤诊治指南[J]. 临床肝胆病杂志, 2015,31(11):1752⁃1769. doi: 10. 3969/j.issn.1001⁃5256.2015.11.002.
|
[6] |
Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug⁃induced liver injury[J]. Am J Gastroenterol, 2014,109(7):950⁃966; quiz 967. doi: 10.1038/ajg.2014.131.
|
[7] |
陈五波, 林辉龙. 256例药物热的国内文献分析[J]. 药物流行病学杂志, 2015,24(12):750⁃753.
|
[8] |
张晋萍. 药物热82例分析[J]. 医药导报, 2008,27(6):726⁃727. doi: 10.3870/j.issn.1004⁃0781.2008.06.051.
|
[9] |
徐宁, 胡毅坚, 黄小萍. 常用抗生素致药物热临床分析[J]. 中国基层医药, 2011,18(15):2083⁃2084. doi: 10.3760/cma.j.issn. 1008⁃6706.2011.15.038.
|
[10] |
陈成伟. 认真回顾研究史 重视RUCAM量表在药物性肝损伤诊断中的应用[J]. 中华肝脏病杂志, 2016,24(11):801⁃803. doi: 10.3760/cma.j.issn.1007⁃3418.2016.11.001.
|
[11] |
Danan G, Teschke R. Drug⁃induced liver injury: why is the Roussel Uclaf Causality Assessment Method (RUCAM) still used 25 years after its launch?[J]. Drug Saf, 2018,41(8):735⁃743. doi: 10.1007/s40264⁃018⁃0654⁃2.
|
[12] |
Chalasani NP, Maddur H, Russo MW, et al. ACG clinical guideline: diagnosis and management of idiosyncratic drug⁃induced liver injury[J]. Am J Gastroenterol, 2021,116(5):878⁃898. doi:10.14309/ajg.0000000000001259.
|
[13] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: drug⁃induced liver injury[J]. J Hepatol, 2019,70(6):1222⁃1261. doi: 10.1016/j.jhep.2019.02.014.
|
[14] |
Devarbhavi H, Aithal G, Treeprasertsuk S, et al. Drug⁃induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines[J]. Hepatol Int, 2021,15(2):258⁃282. doi: 10.1007/s12072⁃021⁃10144⁃3.
|
[15] |
Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug⁃induced liver injury: the DILIN prospective study[J]. Gastroenterology, 2015,148(7):1340⁃1352.e7. doi: 10.1053/j.gastro.2015.03.006.
|
[16] |
Lee T, Lee YS, Yoon SY, et al. Characteristics of liver injury in drug⁃induced systemic hypersensitivity reactions[J]. J Am Acad Dermatol, 2013,69(3):407⁃415. doi: 10.1016/j.jaad.2013.03.024.
|
[17] |
Su P, Aw CW. Severe cutaneous adverse reactions in a local hospital setting: a 5⁃year retrospective study[J]. Int J Dermatol, 2014,53(11):1339⁃1345. doi: 10.1111/ijd.12118.
|
[18] |
Zhang Z, Li S, Zhang Z, et al. Clinical features, risk factors, and prognostic markers of drug⁃induced liver injury in patients with Stevens⁃Johnson syndrome/toxic epidermal necrolysis[J]. Indian J Dermatol, 2020,65(4):274⁃278. doi: 10.4103/ijd.IJD_217_19.
|
[19] |
Fang WC, Adler NR, Graudins LV, et al. Drug⁃induced liver injury is frequently associated with severe cutaneous adverse drug reactions: experience from two Australian tertiary hospitals[J]. Intern Med J, 2018,48(5):549⁃555. doi: 10.1111/imj.13734.
|
[20] |
Skowron F, Bensaid B, Balme B, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases[J]. J Eur Acad Dermatol Venereol, 2015,29(11):2199⁃2205. doi: 10.1111/jdv.13212.
|
[21] |
Lin IC, Yang HC, Strong C, et al. Liver injury in patients with DRESS: a clinical study of 72 cases[J]. J Am Acad Dermatol, 2015,72(6):984⁃991. doi: 10.1016/j.jaad.2015.02.1130.
|
[22] |
宋芳娇, 翟庆慧, 贺庆娟, 等. 2 820例药物性肝损伤临床分析[J]. 中华肝脏病杂志, 2020,28(11):954⁃958. doi: 10.3760/cma.j.cn501113⁃20200609⁃00305.
|
[23] |
张丽媛, 刘昌江, 杜永国, 等. 430例药物性肝损伤临床特点分析[J]. 肝脏, 2019,24(5):519⁃521. doi: 10.3969/j.issn.1008⁃1704.2019.05.013.
|
[24] |
Andrade RJ, Lucena MI, Fernández MC, et al. Drug⁃induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10⁃year period[J]. Gastroenterology, 2005,129(2):512⁃521. doi: 10.1016/j.gastro.2005.05.006.
|
[25] |
Fontana RJ, Hayashi PH, Barnhart H,et al. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury[J]. Am J Gastroenterol, 2015,110(10):1450⁃1459. doi: 10.1038/ajg.2015. 283.
|
[26] |
Pang L, Yang W, Hou F. Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug⁃induced liver injury [J]. Clin Res Hepatol Gastroenterol. 2018,42(1):48⁃56. doi: 10.1016/j.clinre.2017.08.003.
|
[27] |
Andrade RJ, Lucena MI, Kaplowitz N, et al. Outcome of acute idiosyncratic drug⁃induced liver injury: Long⁃term follow⁃up in a hepatotoxicity registry[J]. Hepatology, 2006,44(6):1581⁃1588. doi: 10.1002/hep.21424.
|